Improving medicine adherence in kidney transplantatio

Not Applicable

Completed

• Conditions: End-stage kidney disease requiring kidney transplantation; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12614000608662
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Comprehend English, and prescribed immunosuppressant medicines in kidney transplantation

Exclusion Criteria

Adults living in supported accommodation (medicines are managed by staff)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
7% improvement in immunosuppressant medicine adherence compared to ‘usual care’ in kidney transplantation measured by the Medication Event Monitoring System, laboratory tests, prescription refill and self-report.[Outcomes will be assessed at baseline, 3, 6 and 9 months.]

Secondary Outcome Measures

Name	Time	Method
Medicine adherence will be set at equal to or >80% for all other medicines assessed by prescription refill, laboratory tests, and self-report.[Outcomes will be assessed at baseline, 3, 6 and 9 months.]